Biosimilar Interchangeability Designation Would Be Nixed Under Biden Proposal

 
• By Derrick Gingery

The proposal is not expected to cost or save the government money, but is expected to increase biosimilar uptake, according to budget documents.

budget
The FDA would receive about $7.2bn in budget authority and user fees in Biden's FY 2025 budget request. • Source: Shutterstock

More from Biosimilars

More from Biosimilars & Generics